Added to YB: 2019-08-22
Pitch date: 2019-08-22
ZIOP [bearish]
Alaunos Therapeutics, Inc.
+99.75%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders.
Market Cap
$6.3M
Pitch Price
$844.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.45
P/E
-1.27
EV/Sales
2.0K
Sector
Biotechnology
Category
N/A
Show full summary:
ZIOPHARM ONCOLOGY INC ZIOP
A summary for this pitch has not been created yet.
Read full article (0 min)